Higher NAD+ levels and better mitochondrial function mean cells can respond more robustly to anabolic signals
MOTS-c is a mitochondrial-derived peptide that activates AMPK, the same metabolic switch exercise and fasting flip, improving insulin sensitivity, mitochondrial function, and metabolic flexibility
Adding too much water dilutes the solution, potentially requiring larger injection volumes that increase discomfort
For a broader overview of the regulatory landscape, see our are research peptides legal in 2026 explainer
It is essential to distinguish medically indicated B12 replacement therapy from commercially marketed wellness injections, as they serve fundamentally different purposes and are subject to different regulatory oversight
This compound is not approved by the FDA for human use and is not intended for human consumption or self-administration